MUMBAI (Reuters) - Indian drugmaker Wockhardt is proving there is life after debt restructuring. After defaulting on $110 million in overseas bonds in 2009 and renegotiating payment on 13 billion ...
MUMBAI, June 20 (Reuters) - Indian drug maker Wockhardt Ltd. said on Wednesday it had received approval from the U.S. Food and Drug Administration to market cefprozil tablets. The antibiotic, used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback